Cognitive Dysfunction

The grounding does not support a single cause for cognitive dysfunction as a standalone disease entity. In the reviewed literature, cognitive impairment is associated with Alzheimer disease pathology, mild cognitive impairment, and schizophrenia, but no unified aetiology is provided.

The supplied reviews link cognitive dysfunction to Alzheimer disease neuropathology, including amyloid plaques, cerebral amyloid angiopathy, neurofibrillary tangles, glial responses, neuronal loss, and synaptic loss. Other mechanisms mentioned include altered neuronal plasticity, signal transduction, cerebrovascular circulation, aging, and neurotransmitter-related mechanisms in schizophrenia such as dopamine, cholinergic signalling, and the balance between GABAergic interneurons and glutamatergic pyramidal cells.

The grounding supports aging and mild cognitive impairment as contexts associated with cognitive decline, and it notes a continuum between normal aging and Alzheimer disease dementia. It also indicates that genetic and environmental factors can be associated with cognitive function in schizophrenia, but does not specify particular risk factors for cognitive dysfunction as a standalone condition.

The supplied material supports assessment with validated cognitive tools and neuropsychological testing, with diagnostic work-up informed by biomarkers and imaging in Alzheimer disease-related contexts. For mild cognitive impairment, no high-quality evidence supports pharmacologic treatment, while exercise training and cognitive training may improve cognitive measures; the schizophrenia review also notes that existing treatments do not adequately address cognitive deficits and discusses candidate novel treatments rather than established therapy classes.